AI-powered risk stratification for cancer patient care
ArteraAI uses multimodal AI technology to analyze pathology images and patient data, providing personalized prognostic risk scores for cancer treatment.
Digital pathology platform with integrated AI for diagnostic
Proscia powers precision medicine and clinical case review through its digital pathology platform, connecting laboratories and pharmaceutical researchers.